Ravi Yang Sarin reported a 4.7% stake in Starling Oncology STLN · 4,109,771 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 4.7%
Last report: No earlier report
Shares held: 4,109,771 sh
Class: Common Stock, par value $0.0001 per share
Stock: Starling Oncology STLN
Holder: Ravi Yang Sarin
Event date: 25/03/26
Filed: 25/04/23

4.7% stake · below 5%

Starling Oncology trades, last 26 weeks

What else happened in Starling Oncology around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Ravi Yang Sarin's other 5% stake reports

No other trades yet.